Table of Content

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase In Adoption Of EHR’s And Information Technology Related Services
4.1.1.2. Increase In The Prevalence Of The Chronic Disease Lead To Advancements In Healthcare Management
4.1.2. Restraints:
4.1.2.1. Privacy, Data Security-Related Issues And Lack Of Availability Of Skilled & Trained Resources
4.1.3. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Disease Registry Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
7.1.2. Market Attractiveness Index, By Disease Registry Type
7.2. Alzheimer’s Disease *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Diabetes
7.4. Orthopaedics
7.5. Cardiovascular
7.6. Cancer
7.7. Others
8. By Functionality Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
8.1.2. Market Attractiveness Index, By Functionality Type
8.2. Patient Care Management*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Health Information Exchange (HIC)
8.4. Point Of Care (POC)
8.5. Research
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Pharmaceutical companies
9.4. Clinical laboratories
9.5. Others
10. By Software Type
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
10.1.2. Market Attractiveness Index, By Software Type
10.2. Integrated*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Stand-alone
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Registry Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Type
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Software Type
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Treatment type Benchmarking
13. Company Profiles
13.1. Dacima Software Inc*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. McKesson Corporation
13.3. Global Vision Technologies Inc.
13.4. ImageTrend Inc.
13.5. Liaison Technologies.
13.6. Optum Inc.
13.7. Phytel Inc.
13.8. Quintiles IMS Holdings Inc
LIST NOT EXHAUSTIVE
14. Global Patient Registry Software market– DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us